JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY) ›› 2017, Vol. 31 ›› Issue (1): 123-126.doi: 10.6040/j.issn.1673-3770.0.2016.454

Previous Articles     Next Articles

The pathogenesis of RVO and anti-VEGF treatment for its macular edema.

  

  1. 1. The Second School of Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan 250001, Shandong, China;2. The Ophthalmic Hospital Affiliated to Shandong University of Traditional Chinese Medicine, Jinan 250003, Shandong, China;3. The First School of Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan 250014, Shandong, China;4. Ophthalmic Center Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, Shandong, China
  • Received:2016-11-01 Online:2017-02-16 Published:2017-02-16

PDF (PC)

1178

Abstract: RVO is a common retinal vascular disease. Macular edema is one of major cause to induce visual damage. With the application of anti-VEGF drug in clinic, macular edema can be reduced and vision is improved. The essay mainly summarized the epidemiologies and mechanisms of retinal vein occlusion and the treatment of macular edema with anti-VEGF reagents.

Key words: Macular edema, Retinal vein occlusion, Anti-VEGF

CLC Number: 

  • R774
[1] 董宁. 视网膜静脉阻塞与血浆同型半胱氨酸、维生素B12和叶酸水平以及C677T MTHFR基因多态性的相关研究[D].天津:天津医科大学,2015.
[2] Dacheva I, Ullmer C, Ceglowska K, et al. Lysophosphatidic acids and autotaxin inretinal vein occlusion[J]. Retina, 2016, 36(12):2311-2318.
[3] Kuhli-Hattenbach C, Hellstern P, Miesbach W, et al. Prevalence of elevated lipoprotein(a)levels in patients <60 years of age with retinal vein occlusion[J]. Klin Monbl Augenheilkd, 2016.
[4] Stanca HT, Manea G. Physiopathology of macular edema in central vein Occlusion[J]. Oftalmologia, 2012, 56(2):15-20.
[5] Ojima T, Takagi H, Suzuma K, et al. EphrinA1 inhibits vascular endothelial growth factor-induced intracellular signaling and supper-sses retinal neovascularization and blood-retinal barrier breakdown[J]. Am J Pathol, 2006, 168(1):331-339.
[6] Campochiaro PA, Aiello LP, Rosenfeld PJ. Anti-vascular endothelial growth factor agents in the treatment of retinal disease: from bench to bedside[J]. Ophthalmology, 2016, 123(10):S78-S88.
[7] Glanville J, Patterson J, McCool R, et al. Efficacy and safety of widely used treatments for macular oeddema secondary to retinal vein occlusion: a systematic review[J]. BMC Ophthalmol, 2014, 14(7):1-15.
[8] Campochiaro PA, Bhisitkul RB, Shapiro H, et al. Vascular endothelial growth factor promotes progressive retinal nonperfusion in patients with retinal vein occlusion[J]. Ophthalmology, 2013, 120(4):795- 802.
[9] 孟晓丽,冯俊. 视网膜分支静脉阻塞黄斑水肿的研究概况[J].中国中医眼科杂志,2014,24(1):66-69. MENG Xiaoli, FENG Jun. Research survey on macular edema of branch retinal vein occlusion[J]. Chin J Chin Ophthalmol, 2014, 24(1):66-69.
[10] Rogers SL, McIntosh RL, Lim L, et al. Natural history of branch retinal vein occlusion:an evidence-based systematic review[J]. Ophthalmology, 2010, 117(6):1094-1101.
[11] McIntosh RL, Rogers SL, Lim L, et al. Natural history of central retinal vein occlusion:an evidence-based systematic review[J]. Ophthalmology, 2010, 117(6):1113-1123.
[12] 张璐,赵博军.视网膜静脉阻塞引起黄斑水肿的药物治疗进展[J]. 国际眼科杂志,2013,13(11):2227-2230. ZHANG Lu, ZHAO Bojun. Advance in pharmaco-therapy of macular edema in retinal vein occlusion[J]. Int Eye Sci, 2013, 13(11):2227-2230.
[13] 刘卫. 视网膜静脉阻塞继发黄斑水肿的治疗进展[J]. 中国眼耳鼻喉科杂志,2015,15(4):236-239.
[14] 黄厚斌,张卯年. 抗VEGF药物治疗视网膜静脉阻塞黄斑水肿的疗效及安全性评价[J]. 眼科新进展,2013,33(1):1-4. HUANG Houbin, ZHANG Maonian. Curative effects and safety evaluation of unti-VEGF drugs of macular edema induced by retinal vein occlusion[J]. Recent Advan Ophthalmol, 2013, 33(1):1-4.
[15] Zhang S, An N, Ha W, et al. Factors correlated with the resolution of macular oedema after one dose injection of intravitreal triamcinolone acetonide treatment in branch retinal vein occlusion[J]. J Int Med Res, 2016, 44(3):685-697.
[16] Tomiyasu T, Hirano Y, Yoshida M, et al. Microaneurysms cause refractory macular edema in branch retinal vein occlusion[J]. Sci Rep, 2016(6):29445.
[17] Sellam A, Glacet-Bernard A, Coscas F, et al. Qualitative and quantitative follow-up using optical coherence tomography angiography of retinal vein occlusion treated with anti-vegf: optical coherence tomography angiography follow-up of retinal vein occlusion[J]. Retina, 2016.
[18] Fujihara-Mino A, Mitamura Y, Inomoto N, et al. Optical coherence tomography parameters predictive of visual outcome after anti-VEGF therapy for retinal vein occlusion[J]. Clin Ophthalmol, 2016(10):1305-1313.
[19] Casselholmde Salles M, Kvanta A, Amrén U, et al. Optical coherence tomography angiography in central retinal vein occlusion: correlation between the foveal avascular zone and visual acuity[J]. Invest Ophthalmol Vis Sci, 2016, 57(9):242-246.
[20] Balaratnasingam C, Inoue M, Ahn S, et al. Visual acuity is correlated with the area of the foveal avascular zone in diabetic retinopathy and retinal vein occlusion[J]. Ophthalmology, 2016, 123(11):2352-2367.
[1] ZHU Mingqiong, LI Zheng, LIU Ru, TIAN Tao, PENG Jingli, LYU Qianyi, TAN Huaxia. The application of AI screening system based on OCT/OCTA in the evaluation of the effect of anti VEGF treatment in patients with diabetes macular edema [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 68-73.
[2] SUN Qingzhu, SHEN Jian, CHEN Xing, WU Yanbing, ZENG Lun. The role of metabolic indicators in predicting ranibizumab efficacy in diabetic macular edema [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 74-81.
[3] ZHU Yunlong, WANG Ping, GAO Meng. A case of posterior scleritis initially misdiagnosed as central serous chorioretinopathy and retinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 99-105.
[4] DING Shuliang, WANG Chaofan, LIU Jianliang. A case of intraocular fluid detection to guide precise treatment of acute retinal necrosis and review of the literature [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 114-117.
[5] SHEN Jiaqi, LI Xiaosa, BI Yanlong, ZHANG Jingfa. The application of artificial intelligence in screening, diagnosis and prognosis of diabetic macular edema [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(5): 153-159.
[6] AI Zhaohui, ZHANG Jie. Research progress in the diagnosis and treatment of incontinentia pigmenti-related eye diseases [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(4): 166-174.
[7] BAO Ying, LIU Zhigao, JANG Pengfei, CUI Wenxuan, ZHENG Xiaoxia, YANG Mengyao, SI Mingwei, WANG Yu, WANG Hong. Clinical observation of compacept in the treatment of diabetes mellitus with CRVO-ME high reflex point [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(3): 55-60.
[8] CHANG Weiwei, JIAO Wanzhen, CUI Yanyan, ZHAO Jie, LIU Zhaoqiang, ZHAO Bojun. Research progress of diabetic macular ischaemia [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(3): 130-136.
[9] ZHOU Jinglin, LI Jinxiang, ZENG Qi. Effect of 577 nm subthreshold micropulse laser photocoagulation combined with anti-VEGF on the treatment of refractory diabetic macular edema [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(2): 18-25.
[10] HE Jing, LEI Chunyan, ZHANG Meixia. Association of glycosylated hemoglobin variation index with diabetic retinopathy severity [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(2): 34-40.
[11] LIU Tianwei, ZHAO Bojun. Research progress on retinal vein occlusion in young people [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(1): 128-137.
[12] TANG Huixin, LI Jingjing, ZOU Hong. Mechanism and clinical applications of subthreshold diode micropulse laser [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(3): 143-148.
[13] GU Ranran, LI Fengjiao, JIAO Wanzhen, CUI Yanyan, ZHAO Bojun. Clinical efficacy of lecithin complex iodine capsule in the adjuvant treatment of retinal vein occlusion [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(5): 46-50.
[14] PAN Yanli, LI Yuanbin. Treatment of pseudygium with anti-VEGF corneal matrix injection combined with operation: a case report [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(2): 96-99.
[15] Keyang HAN,Beibei YU,Bojun ZHAO. Morphological structure analysis of the macular area after anti-VEGF treatment for short-term retinal vein occlusion [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(5): 129-131.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd